William Blair Downgrades Fusion Pharmaceuticals (FUSN) to Market Perform

March 19, 2024 10:47 AM

William Blair analyst Andy Hsieh downgraded Fusion Pharmaceuticals (NASDAQ ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found